Arbutus Biopharma Corp (ABUS) — Tangible Net Worth Ratio
Arbutus Biopharma Corp (ABUS) has a Tangible Net Worth Ratio of 100.0% as of March 2026. This metric is calculated by deducting intangible assets ($0.00) from net assets ($260.18 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See ABUS total equity for net asset value and shareholders' equity analysis.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Arbutus Biopharma Corp Tangible Net Worth Ratio (1998–2025)
This chart shows how Arbutus Biopharma Corp's Tangible Net Worth Ratio has changed across 26 annual periods from 1998 to 2025. As of March 2026, the ratio stands at 100.0%, reflecting net assets of $260.18 Million with intangible assets of $0.00 USD. Also explore Arbutus Biopharma Corp net asset momentum to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for Arbutus Biopharma Corp (1998–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Arbutus Biopharma Corp from 1998 to 2025, covering 26 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see market cap of Arbutus Biopharma Corp.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 100.0% | $76.58 Million | $0.00 | $94.62 Million | ▲ +0.0 pp |
| 2024 | 100.0% | $97.37 Million | $0.00 | $131.71 Million | ▲ +0.0 pp |
| 2023 | 100.0% | $106.02 Million | $0.00 | $144.40 Million | ▲ +0.0 pp |
| 2022 | 100.0% | $136.85 Million | $0.00 | $195.42 Million | ▲ +0.0 pp |
| 2021 | 100.0% | $169.44 Million | $0.00 | $204.49 Million | ▲ +0.0 pp |
| 2020 | 100.0% | $101.97 Million | $0.00 | $137.08 Million | ▲ +0.0 pp |
| 2019 | 100.0% | $72.74 Million | $0.00 | $105.53 Million | ▲ +21.9 pp |
| 2018 | 78.1% | $200.23 Million | $43.84 Million | $227.91 Million | ▲ +10.2 pp |
| 2017 | 67.9% | $182.50 Million | $58.60 Million | $237.20 Million | ▲ +16.9 pp |
| 2016 | 51.0% | $203.00 Million | $99.40 Million | $275.90 Million | ▲ +15.4 pp |
| 2015 | 35.6% | $547.68 Million | $352.64 Million | $712.29 Million | ▼ -64.4 pp |
| 2014 | 100.0% | $88.00 Million | $0.00 | $118.20 Million | ▲ +0.0 pp |
| 2013 | 100.0% | $59.19 Million | $0.00 | $71.72 Million | ▲ +0.0 pp |
| 2012 | 100.0% | $40.92 Million | $0.00 | $52.60 Million | ▲ +0.0 pp |
| 2011 | 100.0% | $5.21 Million | $0.00 | $13.70 Million | ▲ +0.0 pp |
| 2010 | 100.0% | $10.73 Million | $0.00 | $21.02 Million | ▲ +40.8 pp |
| 2009 | 59.2% | $35.44 Million | $14.47 Million | $41.95 Million | ▼ -7.2 pp |
| 2008 | 66.4% | $38.29 Million | $12.87 Million | $42.34 Million | ▼ -33.6 pp |
| 2007 | 100.0% | $18.37 Million | $0.00 | $24.83 Million | ▲ +0.0 pp |
| 2006 | 100.0% | $155.53K | $0.00 | $6.03 Million | ▲ +0.9 pp |
| 2003 | 99.1% | $43.38 Million | $390.25K | $50.73 Million | ▲ +0.2 pp |
| 2002 | 98.9% | $45.35 Million | $520.38K | $53.22 Million | ▲ +2.1 pp |
| 2001 | 96.8% | $61.49 Million | $2.00 Million | $67.60 Million | ▼ -0.6 pp |
| 2000 | 97.3% | $30.03 Million | $801.06K | $32.52 Million | ▼ -0.7 pp |
| 1999 | 98.0% | $26.88 Million | $532.01K | $28.80 Million | ▼ -0.5 pp |
| 1998 | 98.5% | $14.43 Million | $212.38K | $15.83 Million | — |